By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a pair of Phase 2 studies assessing the
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of early Alzheimer’s disease, failed to meet its primary endpoints. The Swiss pharma company ROG, -3.72% Read more PROVIDENCE, R.I. (Project Syndicate)—This week’s United Nations Climate Change Conference (COP27) in Egypt highlights the growing consensus that multilateral cooperation is necessary to avert environmental catastrophe. But with geopolitical tensions Read more By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free survival. The Read more Apple Inc. reportedly has put a pause on hiring for positions that aren’t in research and development, joining a string of other tech companies that are scaling back their once-robust Read more In an economic slowdown, investors should own stocks that return cash to shareholders, rather than shares of companies that invest in capital expenditures and in research and development, said Goldman Read more BOSTON (Project Syndicate)—China highlights a long-debated question about economic development: Can a top-down autocracy outperform liberal market economies in terms of innovation and growth? Between 1980 and 2019, China’s average Read more Rents in Boston are soaring past housing costs in famously pricey California cities like San Francisco and San Jose, making it the country’s second most expensive city for tenants, according to Read more AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with Faslodex combined with a placebo in a Phase 3 trial in advanced hormone receptor-positive breast Read more Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug to treat adult paroxysmal nocturnal hemoglobinuria, a red blood cell condition, has met its two primary Read more
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Opinion: Opinion: Global cooperation is not necessary to fight climate change
GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
Apple reportedly pauses hiring for many roles, joining Amazon in belt-tightening
Invest in stocks that return cash to shareholders in an economic slowdown, says Goldman
Opinion: China’s economy is rotting from the head
New York has the most expensive rents in the U.S. This city is No. 2…
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
Novartis hemoglobinuria trial meets two primary endpoints